Lead and catechol hematotoxicity in vitro using human and murine hematopoietic progenitor cells

Cell Biology and Toxicology

Volumn 15, Issue 2, 1999, Pages 101-110

  Van Den Heuvel, Rosette L ^a   Leppens, H ^a   Schoeters, G E R ^a  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

Author keywords

Catechol; Cord blood; Hematopoietic progenitors; Hematotoxicity; In vitro; Lead

Indexed keywords

BENZENE; CATECHOL; LEAD;

ANIMAL CELL; ARTICLE; BLOOD TOXICITY; BURST FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEAD POISONING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ANIMALS; CATECHOLS; CELL DIVISION; HEMATOPOIETIC STEM CELLS; HUMANS; LEAD; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 0033036248     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007573414306     Document Type: Article

References (55)

1. Abraham NG. Haematopoietic effects of benzene inhalation assessed by long-term bone marrow culture. Environ Health Perspect. 1996;104:1277-87.
2. Alexander BH, Checkoway H, Costa-Mallen P et al. Interaction of blood lead and δ-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect. 1998; 106:213-6.
3. Amess J. Haematotoxicology. In: Ballantyne B, Mars T, Turner P, eds. General and applied toxicology. New York: Stockton Press; 1993:839-67.
4. Angerer J, Scherer G, Schaller KH, Muller J. The determination of benzene in human blood as an indicator of environmental exposure to volatile aromatic compounds. Fresenius J Anal Chem. 1991;339:740-2.
5. Aksoy M. Malignancies due to occupational exposure to benzene. Am J Ind Med. 1985;7:395-402.
6. Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Wooten JV. Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem. 1994;40:1401-4.
7. Bois FY, Jackson ET, Pekari K, Smith MT. Population toxicokinetics of benzene. Environ Health Perspect. 1996; 104(6):1405-11.
8. Boucher A, Rio B, Guinard-Flament J, Parent-Massin D. In vitro effects of lead acetate on human erythroblastic progenitors. Toxicol Lett.1998;95(1):127.
9. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable haematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828-32.
10. Brugnone F, Perbelli L, Romeo L, et al. Environmental exposure and blood levels of benzene in gas station attendants: comparison with the general population. Med Lav. 1997;88:131-47.
11. Calderon-Salinas JV, Hernandez-Luna C, Valdez-Anaya B, Maldonado-Vega M, Lopez-Miranda A. Evolution of lead toxicity in a population of children. Hum Exp Toxicol. 1996; 15:376-82.
12. Cikrt M, Smerhovsky Z, Blaha K, et al. Biological monitoring of child lead exposure in the Czech Republic. Environ Health Perspect. 1997;105:406-11.
13. Cronkite EP. Benzene hematotoxicity and leukemogenesis. Blood Cells. 1986;12:129-37.
14. Cronkite EP, Inoue T, Carsten AL, Miller ME, Bullis JE, Drew RT. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol Environ Health. 1982;9:411-21.
15. Church JJ, Day P, Braithwaite RA, Brown SS. The speciation of lead in erythrocytes in relation to lead toxicity: case study of two lead-exposed workers. Neurotoxicology. 1993;14:359-64.
16. Cory-Slechta DA. Lead poisoning. In: Corn M, ed. Handbook of hazardous materials. New York: Academic Press; 1993: 411-29.
17. Deldar A, Stevens CE. Development and application of in vitro models of hematopoiesis to drug development. Toxicol Pathol. 1993;21:231-40.
18. Ennever FK, Zaccaro DJ, Fernando RA, Jones BT. Blood lead levels in North Carolina painters. Hum Exp Toxicol. 1995; 14:456-61.
19. Fuller J, Woodman DD. Haematology in toxicology studies. In: Ballantyne B, Mars T, Turner P, eds. General and applied toxicology. New York: Stockton Press; 1993:267-302.
20. Gribaldo L, Bueren A, Deldar A, et al. The use of in vitro systems for evaluating haematotocicity. ATLA. 1996;24: 211-31.
21. Goyer RA. Lead. In: Seiler HG, Sigel H, eds. Handbook on toxicity of inorganic compounds. New York: Marcel Dekker; 1988:359-82.
22. Harris DT, Schumacher MJ, Rychlik S, et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994; 13:135-43.
23. Henderson RF, Sabourin PJ, Bechtold WE, et al. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ Health Perspect. 1989;82:9-18.
24. Jones TD, Morris MD, Hasan JS. Modeling marrow damage from response data: evolution from radiation biology to benzene toxicity. Environ Health Perspect. 1996;104:1293-302.
25. Kalf GF, Schlosser MJ, Renz JF, Pirozzi SJ. Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs. Environ Health Perspect. 1989;82:57-64.
26. Lautraite S, Parent-Massin D, Rio B, Hoellinger H. Comparison of toxicity induced by HT-2 toxin on human and rat granulo-monocytic progenitors with an in vitro model. Hum Exp Toxicol. 1996;15:208-13.
27. 0 and entry into the cell cycle of primitive human haematopoietic progenitors. Proc Natl Acad Sci USA. 1992;89:4013-17.
28. Lutton JD, Ibraham NG, Friedland M, Levere RD. The toxic effects of heavy metals on rat bone marrow in vitro erythropoiesis: protective role of hemin and zinc. Environ Res. 1984;35:97-103.
29. Marley SB, Amos TAS, Gordon MY. Kinetics of colony formation by BFU-E grown under different culture conditions in vitro. Br J Haematol. 1996;92:559-61.
30. Moolenaar RL, Hefflin BJ, Ashley DL, Middaugh JP, Etzel RA. Blood benzene concentrations in workers exposed to oxygenated fuel in Fairbanks' Alaska. Int Arch Occup Environ Health. 1997;69:139-43.
31. Neumeier G. Criteria document for benzene. CEC. Occupational exposure limits. EUR 14491;1993.
32. Noble C, Sina JF. Usefulness of the in vitro bone marrow colony forming assay in cellular toxicology. In Vitro Toxicol. 1993; 6:187-95.
33. Parent-Massin D, Thouvenot D. In vitro study of pesticide hematotoxicity in human and rat progenitors. J Pharmacol Toxicol Meth. 1993; 30:203-7.
34. Parent-Massin D, Thouvenot D. In vitro toxicity of trichothecenes on rat haematopoietic progenitors. Food Addit Contam. 1995;12:41-9.
35. Parent-Massin D, Thouvenot D, Riche C. Lindane haematotoxicity confirmed by in vitro tests on human and rat progenitors. Hum Exp Toxicol. 1994;13:103-6.
36. Romieu I, Lacasana M, McConnell R and the Lead Research Group of the Pan-American Health Organization. Lead exposure in Latin America and the Caribbean. Environ Health Perspect. 1997;105:398-405.
37. Rubenstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119-22.
38. San Roman J, Kamali V, Sibanda B, Weintraub JP, Gee JM, Naughton BA. Measurement of differential hematotoxicity using long-term bone marrow cultures. In Vitro Toxicol. 1994;7:291-9.
39. Scheding S, Loeffler M, Schmitz S, Seidel HJ, Wichmann HE. Hematotoxic effects of benzene analysed by mathematical modeling. Toxicology. 1992;?:265-79.
40. 226Ra approached by haematopoietic stem cell studies in various bone marrow sites of contaminated mice. Health Phys. 1983;44:555-70.
41. Schoeters GER, Vander Plaetse F, Leppens H, Van Vlasselaer P, Van Den Heuvel R. Haematopoietic and osteogenic toxicity testing in vitro using murine bone marrow cultures. Toxicol In Vitro. 1995;9:421-8.
42. Seidel HJ, Barthel E, Zinser D. The haematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp Hematol. 1989a;17:300-3.
43. Seidel HJ, Beyvers G, Pape M, Barthel E. The influence of benzene on the erythroid cell system in mice. Exp Hematol. 1989b;17:760-4.
44. Seidel HJ, Barthel E, Schäfer F, Schad H, Weber L. Action of benzene metabolites on murine haematopoietic colony-forming cells in vitro. Toxicol Appl Pharmacol. 1991;111: 128-31.
45. Smith CM, Wang X, Hu H, Kelsey KT. Dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect. 1995;103:248-53.
46. Snyder R, Kalf G. A perspective on benzene leukomogenesis. CRC Crit Rev Toxicol. 1994;24:177-209.
47. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect. 1996;104:1165-72.
48. Sutherland HJ, Eaves AD, Eaves CJ. Quantitative assays of human haematopoietic progenitor cells. In: Gee AP, ed. Bone marrow processing and purgin: a practical guide. Boca Raton: CRC Press; 1991:155-71.
49. Todd AC, Wetmur JG, Moline JM, Godbold JH, Levin SM, Landrigan PJ. Unraveling the chronic toxicity of lead: an essential priority for environmental health. Environ Health Perspect. 1996;104:141-6.
50. 241Am in utero shows a deficient in vitro haematopoiesis. Int J Radiat Biol. 1990;57:103-15.
51. Van Den Heuvel RL, Schoeters G, Leppens H. Haematotoxicity testing in vitro using human cord blood haematopoietic cells. Toxicol In Vitro. 1997;11:689-93.
52. Wahid A, Koul PA, Shah SU, Khal AR, Bhat MS, Malik MA. Lead exposure in papier mâché workers. Hum Exp Toxicol. 1997;16:281-3.
53. Wierda D, Irons RD. Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology. 1982;2:41-54.
54. Weisel C, Yu R, Roy A, Georgopoulos ? Biomarkers of environmental benzene exposure. Environ Health Perspect. 1996;104:1141-6.
55. WHO. Air quality guidelines for Europe (European Series no. 23). Geneva: World Health Organization; 1987:45-58, 242-61.